2倍做多NVO ETF-Defiance(NVOX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

NVOX 2倍做多NVO ETF-Defiance

已收盘 06-12 16:00:00 EDT

13.63

-0.09

-0.66%

盘后13.51

-0.12-0.92%

19:40 EDT

最高14.09	最低13.57	成交量60.70万
今开13.70	昨收13.72	日振幅3.77%
总市值4,073万	流通市值4,073万	总股本298.81万
成交额838.63万	换手率20.31%	流通股本298.81万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"NVOX","market":"US","secType":"STK","nameCN":"2倍做多NVO ETF-Defiance","latestPrice":13.63,"timestamp":1781294400000,"preClose":13.72,"halted":0,"volume":607021,"hourTrading":{"tag":"盘后","latestPrice":13.505,"preClose":13.63,"latestTime":"19:40 EDT","volume":3504,"amount":48358.213,"timestamp":1781307652676,"change":-0.125,"changeRate":-0.009171,"amplitude":0.028247},"delay":0,"changeRate":-0.0065597667638483854,"floatShares":2988101,"shares":2988101,"eps":0,"marketStatus":"已收盘","change":-0.09,"latestTime":"06-12 16:00:00 EDT","open":13.695,"high":14.085,"low":13.5674,"amount":8386349.615263999,"amplitude":0.037726,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":2,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1781510400000},"marketStatusCode":5,"adr":0,"exchange":"ARCA","adjPreClose":13.72,"sharesOutstanding":4128101,"nav":13.71,"aum":40281364.71,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":13.61,"preClose":13.72,"latestTime":"09:17 EDT","volume":12136,"amount":164348.782408,"timestamp":1781270275143,"change":-0.11,"changeRate":-0.008017,"amplitude":0.033528},"postHourTrading":{"tag":"盘后","latestPrice":13.505,"preClose":13.63,"latestTime":"19:40 EDT","volume":3504,"amount":48358.213,"timestamp":1781307652676,"change":-0.125,"changeRate":-0.009171,"amplitude":0.028247},"volumeRatio":1.038676,"impliedVol":0.6379,"impliedVolPercentile":0.108},"requestUrl":"/m/hq/s/NVOX","defaultTab":"news","newsList":[{"id":"1182087964","title":"英国卫生监管机构批准诺和诺德减肥药Wegovy","url":"https://stock-news.laohu8.com/highlight/detail?id=1182087964","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1182087964?lang=zh_cn&edition=full","pubTime":"2026-06-11 23:19","pubTimestamp":1781191158,"startTime":"0","endTime":"0","summary":"英国药品监管机构周四批准了诺和诺德的减肥药片，为患者提供了一种无需注射的肥胖治疗新选择，同时也巩固了这家丹麦药企相对于美国竞争对手礼来的先发优势。诺和诺德预计，该药将在数周内通过私立处方上市。根据英国国家医疗服务体系的最新估算，英格兰约有30%的成年人受肥胖影响，相当于约1300万至1400万人。诺和诺德这款药片含有司美格鲁肽，与其旗下用于减肥的注射型重磅药物Wegovy及用于糖尿病的Ozempic具有相同的活性成分。","market":"us","thumbnail":"https://community-static.tradeup.com/news/4812f8e146094a91d24ad513651fcb26","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/4812f8e146094a91d24ad513651fcb26"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"a4d9db3d57fa8633379c890f70b5f1d9","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVOX","NVO","NVOH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642424467","title":"减肥药概念股普涨 诺和诺德(NVO)涨3.14% 高盛料2030年全球减肥药市场规模将达1140亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2642424467","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642424467?lang=zh_cn&edition=full","pubTime":"2026-06-10 22:17","pubTimestamp":1781101035,"startTime":"0","endTime":"0","summary":"高盛新近研究指，预计到2030年，全球减肥药市场规模将达到1140亿美元，较去年12月作出的1010亿美元预测进一步上调约13%，因一系列利好因素正在推动这一赛道从“小众高价市场”向“大众消费级市场”转变。基于这一趋势，高盛预计，到2030年口服减肥药将贡献约460亿美元收入，占全球肥胖症药物市场规模的40%，高于此前预计的350亿美元和35%的市场占比。","market":"us","thumbnail":"https://static.szfiu.com/news/20250107/ZjY1NDI1NzQxNDM1Mw==.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/ZjY1NDI1NzQxNDM1Mw==.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"301402","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4007","BK4599","NVOH","LU1093756325.SGD","BK4532","IE00BZ1G4Q59.USD","BK4585","LU1093756168.USD","NVOX","NVO","IE00BKVL7J92.USD","LU0154236417.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642419178","title":"GLP-1赛道竞争加剧  辉瑞“头对头”挑战诺和诺德","url":"https://stock-news.laohu8.com/highlight/detail?id=2642419178","media":"新华财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642419178?lang=zh_cn&edition=full","pubTime":"2026-06-10 09:35","pubTimestamp":1781055326,"startTime":"0","endTime":"0","summary":"新华财经北京6月10日电近日，辉瑞公布其GLP-1受体激动剂埃诺格鲁肽（先维盈?）与诺和诺德司美格鲁肽（诺和盈?）的头对头研究——SLIMMER-UP-SWITCH的20周中期分析结果，显示埃诺格鲁肽在减重数值上略优于司美格鲁肽。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606103766030185.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["NVOX","LU2596442595.SGD","NVO","LU1894683264.USD","LU1057294990.SGD","LU0289739699.SGD","IE00BLSP4239.USD","LU0122379950.USD","SG9999011175.SGD","SGXZ57979304.SGD","LU0306806265.USD","LU1066053197.SGD","LU0058720904.USD","IE00BBT3K403.USD","LU0868494617.USD","BK4534","IE0002270589.USD","SG9999001176.SGD","LU0321505439.SGD","IE00B19Z3581.USD","LU0985481810.HKD","LU1894683348.USD","NVOH","SG9999002224.SGD","BK4588","LU0234572021.USD","LU1883839398.USD","SG9999013999.USD","IE00B19Z3B42.SGD","IE000M9KFDE8.USD","LU0170899867.USD","BK4532","IE00BZ1G4Q59.USD","BK4533","LU0225284248.USD","SG9999002232.USD","BK4585","LU1093756325.SGD","BK4599","LU0154236417.USD","PFE","SG9999001176.USD","BK4007","IE00BLSP4452.SGD","IE00B3T34201.USD","BK4592","BK4550","LU0225771236.USD","LU1023059063.AUD","LU0306807586.USD","LU0321505868.SGD","SG9999003800.SGD","LU1093756168.USD","BK4568","LU1066051498.USD","BK4581","LU0456855351.SGD","IE00BKVL7J92.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642137467","title":"多家药企公布“头对头”司美研究数据，诺和诺德坐不住了","url":"https://stock-news.laohu8.com/highlight/detail?id=2642137467","media":"澎湃新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642137467?lang=zh_cn&edition=full","pubTime":"2026-06-09 19:44","pubTimestamp":1781005440,"startTime":"0","endTime":"0","summary":"减肥药赛道再起波澜！因为一项减肥药的头对头研究数据，诺和诺德向辉瑞“开怼”。6月9日，减肥药巨头诺和诺德中国针对近期在2026年美国糖尿病协会（ADA）科学年会上公布的SLIMMER-UP-SWITCH研究的20周中期分析数据发布了一份说明称：“对于任何单一研究，均需在更完整的数据披露和多维度证据支持下进行综合、科学评估，避免片面解读带来的潜在误导。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202606093765289066.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606093765289066.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0225284248.USD","BK4588","IE00B3T34201.USD","LU0225771236.USD","IE00BKVL7J92.USD","LU1093756325.SGD","BK4581","BK4534","LU0234572021.USD","LU2596442595.SGD","SG9999002232.USD","LU0154236417.USD","NVOX","LU0306806265.USD","LU0289739699.SGD","SG9999003800.SGD","SG9999001176.SGD","LU0122379950.USD","BK4532","IE00B19Z3581.USD","IE00BLSP4239.USD","LU0306807586.USD","PFE","LU1883839398.USD","IE00BBT3K403.USD","IE000M9KFDE8.USD","LU0868494617.USD","NVO","LU0985481810.HKD","LU1066051498.USD","IE0002270589.USD","SG9999011175.SGD","LU1894683348.USD","LU0321505439.SGD","SG9999002224.SGD","LU1093756168.USD","SGXZ57979304.SGD","IE00BLSP4452.SGD","BK4599","LU0170899867.USD","LU1894683264.USD","SG9999013999.USD","BK4568","BK4533","BK4007","SG9999001176.USD","BK4585","LU0456855351.SGD","BK4550","LU1023059063.AUD","BK4592","LU0321505868.SGD","NVOH","IE00B19Z3B42.SGD","IE00BZ1G4Q59.USD","LU0058720904.USD","LU1066053197.SGD","LU1057294990.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641100049","title":"比司美格鲁肽多减35%体重！辉瑞减肥药能否突破GLP-1药物疗效瓶颈","url":"https://stock-news.laohu8.com/highlight/detail?id=2641100049","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641100049?lang=zh_cn&edition=full","pubTime":"2026-06-08 17:17","pubTimestamp":1780910222,"startTime":"0","endTime":"0","summary":"国内GLP-1减肥药市场的竞争，已从“有无”之争进入到拼疗效阶段。6月8日，辉瑞宣布其GLP-1受体激动剂埃诺格鲁肽与司美格鲁肽的头对头研究（SLIMMER-UP-SWITCH）关键数据，在2026年美国糖尿病协会（ADA）科学年会上作为“最新突破（LateBreaking）”正式公布。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202606083763671017.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606083763671017.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0321505868.SGD","LU0225771236.USD","NVOH","LU0234572021.USD","IE000M9KFDE8.USD","IE00BZ1G4Q59.USD","LU1093756168.USD","IE00B19Z3B42.SGD","LU1066051498.USD","IE00B3T34201.USD","BK4568","LU0456855351.SGD","LU0289739699.SGD","LU1057294990.SGD","IE00B19Z3581.USD","LU0868494617.USD","SG9999013999.USD","IE00BLSP4452.SGD","SGXZ57979304.SGD","LU0985481810.HKD","PFE","BK4007","BK4585","NVO","SG9999003800.SGD","LU0154236417.USD","LU1066053197.SGD","BK4532","IE00BBT3K403.USD","LU0225284248.USD","SG9999002232.USD","IE0002270589.USD","LU0058720904.USD","LU0306806265.USD","BK4592","LU1883839398.USD","SG9999001176.SGD","BK4550","BK4534","LU1894683348.USD","LU2596442595.SGD","BK4599","IE00BKVL7J92.USD","LU1093756325.SGD","SG9999011175.SGD","LU1023059063.AUD","SG9999001176.USD","IE00BLSP4239.USD","LU0306807586.USD","NVOX","LU0170899867.USD","BK4533","BK4588","LU0321505439.SGD","BK4581","LU1894683264.USD","SG9999002224.SGD","LU0122379950.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641100657","title":"诺和诺德减肥口服药上市以来处方量已达300万份","url":"https://stock-news.laohu8.com/highlight/detail?id=2641100657","media":"环球市场播报","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641100657?lang=zh_cn&edition=full","pubTime":"2026-06-08 17:07","pubTimestamp":1780909620,"startTime":"0","endTime":"0","summary":"诺和诺德表示，其减肥口服药维秀美自1月初上市以来，处方量已超过300万份。　　这家丹麦制药商周日晚间表示，该口服药在美国药店和在线供应商上架12周后，处方量达到100万份，并在随后的10周内又开出了200万份处方。　　维秀美口服药超过80%的新处方是开给首次使用GLP-1类药物的患者。　　在最初于美国推出维秀美口服药后，诺和诺德上周宣布该药物在阿联酋上市，并表示正准备在今年下半年进行更多地区的上市。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-06-08/doc-iniaswmn5428087.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["NVO","NVOX","BK4532","BK4599","BK4585","BK4007","BK4588","LU0154236417.USD","LU1093756325.SGD","NVOH","IE00BZ1G4Q59.USD","LU1093756168.USD","IE00BKVL7J92.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641110756","title":"诺和诺德、联合健康盘前跌超1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2641110756","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641110756?lang=zh_cn&edition=full","pubTime":"2026-06-08 16:25","pubTimestamp":1780907108,"startTime":"0","endTime":"0","summary":"诺和诺德、联合健康盘前跌超1%","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202606083763608225.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606083763608225.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1720051017.SGD","LU2237443895.HKD","LU0234572021.USD","LU0154236417.USD","IE00BWXC8680.SGD","LU2552382132.HKD","LU0048584097.USD","BK4585","LU0052756011.USD","LU1023059063.AUD","IE00BK4W5M84.HKD","LU2237443549.SGD","LU0094547139.USD","LU1868836757.USD","LU0011850046.USD","IE00B19Z9505.USD","IE00BZ9MQY76.HKD","LU0786609619.USD","LU2237443978.SGD","LU2602419157.SGD","NVO","LU0106261372.USD","IE00BKDWB100.SGD","LU2357305700.SGD","BK4534","LU1712237335.SGD","LU1868837300.USD","LU1127390331.HKD","LU0528227936.USD","LU1548497426.USD","LU1069347547.HKD","IE00B19Z9P08.USD","LU0107464264.USD","LU2361045086.USD","LU0823434583.USD","LU1854104046.USD","IE00BFSS7M15.SGD","LU0345770993.USD","LU1037948897.HKD","LU2089284900.SGD","LU0310799852.SGD","LU0211327993.USD","LU1868836914.USD","LU2023250330.USD","ELIL","LU2264538146.SGD","LU0061475181.USD","IE00B7SZLL34.SGD","IE0001KFT4U8.USD","LU1061106388.HKD","LU0225283273.USD","UNHG","LU0058720904.USD","ELIS","LU1267930490.SGD","LU1066051811.HKD","BK4533","SG9999014914.USD","LU1035775433.USD","IE00B19Z3581.USD","LU0965509101.SGD","LU2471134796.USD","LU0203347892.USD","LU1934455194.USD","LU0882574055.USD","IE00BN29S564.USD","IE00BJJMRZ35.SGD","BK4154","LU0079474960.USD","LU2491050071.SGD","LU1066051498.USD","LU0965509010.AUD","LU2211815571.USD","LU0128525689.USD","LU0385154629.USD","LU0211326755.USD","LU0661504455.SGD","LU0006306889.USD","LU2896262040.SGD","LU0965509283.SGD","LU2237443465.HKD","LU2361044949.HKD","LU1551013342.USD","LU0466842654.USD","LU0310800379.SGD","IE00B2B36J28.USD","LU2237438978.USD","LU1057294990.SGD","LU2089984988.USD","LU1854103824.USD","LU1003077747.HKD","LU1496350502.SGD","SG9999001176.SGD","LLYZ","LU1778281490.HKD","LU0949170772.SGD","SG9999002232.USD","LU2362540622.SGD","LU2237443382.USD","IE00B1XK9C88.USD","LU0823434740.USD","LU0889565916.HKD","LU2552382058.USD","LU2244417387.USD","SG9999015986.USD","LU1674673428.USD","SG9999015978.USD","SG9999018857.SGD","LU0256863902.USD","LU2756315664.SGD","IE00BKVL7J92.USD","LU0266013472.USD","IE00B19Z8X17.USD","IE00B19Z3B42.SGD","LU2125154935.USD","LU2168564065.EUR","BK4007","LU2168563687.JPY","LU1267930730.SGD","LU1914381329.SGD","LU0289739699.SGD","LU2168564222.USD","LU2362541273.HKD","LU1974910355.USD","LU2087625088.SGD","SG9999014898.SGD","SG9999002224.SGD","LU1670627923.USD","LU2461242641.AUD","LU0882574139.USD","IE00BFSS8Q28.SGD","LU0787776722.HKD","LU0471298694.HKD","LU0353189763.USD","LU2023251221.USD","LU0096364046.USD","LU1720051108.HKD","NVOX","SG9999013999.USD","LU1119994496.HKD","LU0211328371.USD","LU0683600562.USD","LU0323591593.USD","LU2360106947.USD","LU2106854487.HKD","IE00B775H168.HKD","LU1988902786.USD","LU1629891620.HKD","IE00B1BXHZ80.USD","LU1280957306.USD","LU1267930573.SGD","LU1804176565.USD","LU0029864427.USD","LU0820561909.HKD","LU2468319806.SGD","LU2063271972.USD","LU1506573853.SGD","LU0823416689.USD","LU2471134952.CNY","LU2360032135.SGD","LU0496365809.HKD","LU1814569148.SGD","SG9999017495.SGD","LU1674673691.USD","LU1934455277.USD","LU2237443622.USD","LU0557290698.USD","LU2111349929.HKD","IE00BK4W5L77.USD","LU0158827781.USD","LLY","LU0203201768.USD","LU2028103732.USD","IE00B4JS1V06.HKD","LU2324357040.USD","LU1267930227.SGD","LU2362541513.USD","LU1551013425.SGD","LU2361044865.SGD","LU0109394709.USD","LU0471298777.SGD","LU1366192091.USD","SG9999015952.SGD","LU1074936037.SGD","IE0004445239.USD","LU0708995401.HKD","LU1066051225.USD","IE00BJJMRY28.SGD","IE0002270589.USD","LU0640476718.USD","SGXZ31699556.SGD","LU1989771016.USD","IE00BJJMRX11.SGD","LU0256863811.USD","LU0553294199.USD","LU0198837287.USD","LU2491050154.USD","LU1791710400.SGD","LU1261432733.SGD","LU0432979614.USD","GB00BDT5M118.USD","LU2023250504.SGD","LU2236285917.USD","LU2462157665.USD","LU0965508806.USD","IE00BFTCPJ56.SGD","IE00B19Z8W00.USD","LU2108987350.USD","IE000M9KFDE8.USD","LU0158827948.USD","LU2471134879.HKD","LU0203202063.USD","LU1093756325.SGD","LU0689472784.USD","LU1791710582.SGD","LU0310800965.SGD","LU1983299246.USD","LU0238689110.USD","LU0251132253.USD","LU0320765992.SGD","IE00BJT1NW94.SGD","LU0342679015.USD","LU0976567544.SGD","LU1917777945.USD","LU0820562030.AUD","LU2279689827.SGD","LLYX","LU0795875169.SGD","LU2746668461.USD","LU2746668974.SGD","IE00BKPKM429.USD","LU0210536198.USD","LU0077335932.USD","LU1934455863.HKD","LU0795875086.SGD","LU2168564495.EUR","BK4588","LU0203345920.USD","LU0133085943.USD","LU0128525929.USD","SGXZ81514606.USD","LU2265009873.SGD","LU0353189680.USD","LU1069344957.HKD","LU0354030438.USD","BK4566","LU0354030511.USD","LU2213496289.HKD","LU0820561818.USD","IE00BSNM7G36.USD","IE00BJLML261.HKD","LU1066053197.SGD","LU1670628061.USD","IE00B19Z9Z06.USD","LU2242649171.HKD","UNH","SGXZ51526630.SGD","LU0861579265.USD","BK4581","LU0149725797.USD","IE0002141913.USD","LU0114720955.EUR","LU0211326839.USD","LU2417539215.USD","LU2471134523.USD","LU1623119135.USD","SGXZ57979304.SGD","IE00BFXG1179.USD","LU1868836591.USD","BK4516","LU2756315318.SGD","NVOH","LU0738911758.USD","LU0417517546.SGD","LU2125154778.USD","IE00B7KXQ091.USD","LU1064131342.USD","LU0345770308.USD","LU0708994859.HKD","LU1732800096.USD","IE00B894F039.SGD","LU1291159041.SGD","LU1145028129.USD","SG9999014906.USD","IE00B4R5TH58.HKD","LU2552382215.SGD","LLII","LU1084165304.USD","BK4599","LU2347655156.SGD","LU1035773651.USD","LU0097036916.USD","LU0456855351.SGD","SG9999018865.SGD","LU1732799900.SGD","LU0943347566.SGD","LU1868837136.USD","BK4532","SG9999014880.SGD","LU0109391861.USD","LU2089283258.USD","SG9999001176.USD","LU0545039389.USD","LU2491049909.HKD","LU2456880835.USD","IE00BZ1G4Q59.USD","LU0187121727.USD","LU0122379950.USD","LU0053666078.USD","IE0005OL40V9.USD","IE0009355771.USD","SGXZ99366536.SGD","LU1093756168.USD","UNHW","LU2271345857.HKD","LU1718418525.SGD","LU0672654240.SGD","LU1232071149.USD","IE00B3T34201.USD","LU2750360997.AUD","SG9999015945.SGD","LU1153585028.USD","LU1037948541.HKD","LU2168564149.EUR","LU2112291526.USD","LU2133065610.SGD","LU2750360641.GBP","LU0912757837.SGD","LU0964807845.USD","LU0320765059.SGD","IE0004445015.USD","LU1323610961.USD","LU0316494557.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1180373682","title":"诺和诺德：司美格鲁肽2毫克在一年期试验中，糖化血红蛋白达标率与替尔泊肽相当，减重达标率更优","url":"https://stock-news.laohu8.com/highlight/detail?id=1180373682","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1180373682?lang=zh_cn&edition=full","pubTime":"2026-06-06 21:04","pubTimestamp":1780751047,"startTime":"0","endTime":"0","summary":"诺和诺德公司研发的司美格鲁肽2毫克剂量，在一项为期一年的临床试验数据中，展现出与礼来公司替尔泊肽在关键血糖控制指标上的同等效力，并在减重效果上实现了超越。\n具体数据显示，接受司美格鲁肽2毫克治疗的患者，其糖化血红蛋白水平成功降至7%以下的比例，与使用替尔泊肽的患者群体相当。然而，在衡量减重效果的另一个关键终点上，司美格鲁肽表现更为突出：治疗一年后，实现体重减轻至少5%的患者比例显著高于替尔泊肽组。\n这一对比结果，为评估这两款在糖尿病与肥胖症治疗领域占据重要地位的药物提供了新的临床依据，凸显了司美格鲁肽在促进显著减重方面的潜在优势。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2089284900.SGD","IE00BWXC8680.SGD","SG9999017495.SGD","LU2360106947.USD","LU2750360641.GBP","IE00BFTCPJ56.SGD","LU0109394709.USD","LU1868836914.USD","SGXZ99366536.SGD","IE0001KFT4U8.USD","LU2271345857.HKD","LU1035775433.USD","LU0096364046.USD","LU0210536198.USD","LU2896262040.SGD","LU0889565916.HKD","SG9999015978.USD","LU1145028129.USD","LU1720051108.HKD","LU1291159041.SGD","LU1093756325.SGD","SG9999013999.USD","LU0061475181.USD","LU0106261372.USD","SG9999015986.USD","IE00BZ1G4Q59.USD","BK4585","LU0006306889.USD","IE0009355771.USD","BK4588","IE00BK4W5L77.USD","LU2089283258.USD","LU1868836591.USD","LU2112291526.USD","LU1868837300.USD","LU1323610961.USD","IE00BFSS8Q28.SGD","LU1366192091.USD","LU0320765059.SGD","SGXZ81514606.USD","BK4533","BK4534","LLYX","LU2211815571.USD","LU0385154629.USD","LU2168564222.USD","LU0238689110.USD","LU2237443895.HKD","LU0964807845.USD","LU2324357040.USD","LU2108987350.USD","IE00BKDWB100.SGD","LU1093756168.USD","NVOX","LU2750360997.AUD","LU0882574055.USD","LU1280957306.USD","LU2602419157.SGD","LU0158827948.USD","LU0154236417.USD","LU1868836757.USD","NVO","LU2023250330.USD","LU2471134952.CNY","LU1983299246.USD","LU0943347566.SGD","LU0708995401.HKD","LU0109391861.USD","LU2357305700.SGD","LU2552382132.HKD","LU2491050154.USD","LU2168564495.EUR","IE00B1XK9C88.USD","LU1720051017.SGD","SG9999018865.SGD","LU2756315318.SGD","LU0689472784.USD","BK4599","LU1712237335.SGD","LU2491050071.SGD","LU2106854487.HKD","LU2237443465.HKD","LU0198837287.USD","LU0266013472.USD","LU2461242641.AUD","LU2023251221.USD","LU2111349929.HKD","BK4007","LU1127390331.HKD","LU2237443978.SGD","LU2456880835.USD","LU0114720955.EUR","LU0323591593.USD","IE00BKPKM429.USD","LU0823434583.USD","LU1064131342.USD","LU0354030438.USD","LU0640476718.USD","LU2237443622.USD","LU2468319806.SGD","LU2462157665.USD","LU0432979614.USD","IE00BJT1NW94.SGD","LU1069344957.HKD","IE00BJLML261.HKD","LU0354030511.USD","LU0786609619.USD","LU1814569148.SGD","LU2361044865.SGD","LU0820561909.HKD","LU2028103732.USD","SG9999015952.SGD","ELIS","IE00BJJMRX11.SGD","IE00BFSS7M15.SGD","LLYZ","LU0256863902.USD","LU0672654240.SGD","IE00BJJMRY28.SGD","LU0289739699.SGD","SGXZ31699556.SGD","SG9999001176.USD","BK4581","IE00BK4W5M84.HKD","LU1629891620.HKD","LU2471134879.HKD","LU0158827781.USD","IE00BKVL7J92.USD","LU0882574139.USD","LU2361045086.USD","LU0787776722.HKD","LU2087625088.SGD","LU2471134796.USD","IE00B2B36J28.USD","IE00BN29S564.USD","LU2089984988.USD","LU1804176565.USD","LU2552382215.SGD","LU2746668461.USD","LU0097036916.USD","LU2746668974.SGD","IE0005OL40V9.USD","SGXZ57979304.SGD","SG9999001176.SGD","SG9999018857.SGD","LU1057294990.SGD","LU1548497426.USD","LU0471298777.SGD","LU2417539215.USD","SG9999014906.USD","LU2213496289.HKD","SG9999014898.SGD","SGXZ51526630.SGD","BK4516","ELIL","LU1917777945.USD","IE00B1BXHZ80.USD","LU2471134523.USD","GB00BDT5M118.USD","IE00B775H168.HKD","LU0122379950.USD","IE00B4R5TH58.HKD","LU0256863811.USD","LU2264538146.SGD","LU0820562030.AUD","LU2168564065.EUR","LU1267930730.SGD","LU1974910355.USD","LU2168564149.EUR","LU0823416689.USD","IE0004445015.USD","LU2237443549.SGD","LU2361044949.HKD","LU0225283273.USD","LU0234572021.USD","LU0417517546.SGD","LU2552382058.USD","LU2265009873.SGD","LLII","LU1551013342.USD","LU2491049909.HKD","LU2236285917.USD","LU0133085943.USD","LU2237443382.USD","LU0203202063.USD","LU0353189680.USD","LU1868837136.USD","LU0683600562.USD","LU0466842654.USD","BK4532","LU1232071149.USD","LU2063271972.USD","LU0823434740.USD","SG9999014880.SGD","LU0820561818.USD","LLY","LU0353189763.USD","LU0471298694.HKD","LU0203201768.USD","LU1061106388.HKD","LU2023250504.SGD","SG9999015945.SGD","LU0456855351.SGD","IE0004445239.USD","LU2168563687.JPY","LU1988902786.USD","LU0320765992.SGD","IE00B4JS1V06.HKD","IE00BJJMRZ35.SGD","LU1023059063.AUD","LU0094547139.USD","NVOH","LU1623119135.USD","LU0316494557.USD","LU0058720904.USD","LU0079474960.USD","LU1551013425.SGD","LU2756315664.SGD","LU2237438978.USD","SG9999014914.USD","IE00B7KXQ091.USD","IE0002141913.USD","LU1989771016.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641149941","title":"需求扩容抵消降价压力 GLP-1赛道远期市场空间再度上调","url":"https://stock-news.laohu8.com/highlight/detail?id=2641149941","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641149941?lang=zh_cn&edition=full","pubTime":"2026-06-05 23:18","pubTimestamp":1780672735,"startTime":"0","endTime":"0","summary":"金吾财讯 | TD Cowen上调GLP-1药物赛道远期市场预期，预计2030年全球GLP-1药物销售额将达1500亿美元，较此前1390亿美元的预测上调8%，较早年1010亿美元预期大幅抬升。需求端增量是赛道核心支撑，该机构预计2030年全球受益患者规模将从4600万增至5900万，用药需求扩容可对冲行业降价带来的营收压力。今年落地的口服GLP-1制剂商业化潜力突出，预计2030年有望占据全球总销售额的14%。","market":"us","thumbnail":"https://static.szfiu.com/news/20210625/YzM0ZmE0OGYyYmI1ZTk0YjVmZmU4ZTU4MTIzMDA2MDU4MDg=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210625/YzM0ZmE0OGYyYmI1ZTk0YjVmZmU4ZTU4MTIzMDA2MDU4MDg=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"301232","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1868836757.USD","LU0266013472.USD","LU2491050071.SGD","ELIS","LU2112291526.USD","LU0882574139.USD","BK4007","LU2471134796.USD","NVOX","LU2602419157.SGD","LU0097036916.USD","LU0471298694.HKD","LU0234572021.USD","LU0320765992.SGD","LU2168564149.EUR","LU1323610961.USD","IE0004445239.USD","LU0114720955.EUR","SG9999017495.SGD","LU1988902786.USD","LU0238689110.USD","LU0456855351.SGD","LU2265009873.SGD","LU1868837300.USD","LU2237438978.USD","ELIL","LU1064131342.USD","BK4516","LU0109394709.USD","IE00BKVL7J92.USD","LU0964807845.USD","LU0417517546.SGD","LU2023251221.USD","LU0289739699.SGD","LU0432979614.USD","LU2361044865.SGD","LU0354030438.USD","LU0820561909.HKD","LU0058720904.USD","BK4585","LU2750360641.GBP","SG9999018857.SGD","LU0158827948.USD","LLY","LU2023250504.SGD","IE00BK4W5M84.HKD","LU1291159041.SGD","LU2028103732.USD","LU2023250330.USD","IE00B4JS1V06.HKD","LU0094547139.USD","LU0096364046.USD","LU1868836591.USD","LU1145028129.USD","LU0122379950.USD","IE0005OL40V9.USD","LU2237443549.SGD","BK4588","SG9999014914.USD","LU2361044949.HKD","LU1551013342.USD","LU0316494557.USD","SG9999015986.USD","LU2237443622.USD","LU0061475181.USD","LU0354030511.USD","LU0353189680.USD","SG9999014880.SGD","LU2746668461.USD","LLYX","IE00B2B36J28.USD","LU2746668974.SGD","SG9999015978.USD","LU2237443978.SGD","LU2108987350.USD","LU2896262040.SGD","LU0385154629.USD","SG9999013999.USD","IE00BFSS8Q28.SGD","IE00BN29S564.USD","LU0256863902.USD","SGXZ81514606.USD","LU1127390331.HKD","LU2360106947.USD","LU2361045086.USD","LU2213496289.HKD","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","LLII","LU1035775433.USD","LU1623119135.USD","LU1974910355.USD","LU2417539215.USD","LU2456880835.USD","LU2089284900.SGD","LU2552382215.SGD","LU1023059063.AUD","SG9999015952.SGD","LU1267930730.SGD","LU0689472784.USD","SG9999014898.SGD","LU0203201768.USD","BK4532","BK4534","LU1804176565.USD","LU2168563687.JPY","SG9999018865.SGD","LU1057294990.SGD","LU2750360997.AUD","IE00BJJMRZ35.SGD","LU1069344957.HKD","LU1629891620.HKD","LU2271345857.HKD","LU2461242641.AUD","LU1720051017.SGD","NVOH","LU0006306889.USD","LU0109391861.USD","LU0683600562.USD","LU0203202063.USD","LU0353189763.USD","LU0882574055.USD","LU1712237335.SGD","LU1814569148.SGD","LU0079474960.USD","LU0708995401.HKD","LU2471134879.HKD","LU2089984988.USD","LU0820561818.USD","IE0001KFT4U8.USD","LU2237443382.USD","SGXZ51526630.SGD","IE00B1BXHZ80.USD","LU2168564222.USD","IE00BJT1NW94.SGD","LU2756315318.SGD","IE00BKPKM429.USD","LU2168564495.EUR","LU0106261372.USD","LU1280957306.USD","LU2471134523.USD","LU1232071149.USD","SGXZ57979304.SGD","LU2491050154.USD","IE0002141913.USD","LU2237443465.HKD","LU0889565916.HKD","LU2236285917.USD","IE00BZ1G4Q59.USD","LU2471134952.CNY","LU0787776722.HKD","LU0256863811.USD","LU0154236417.USD","LU1548497426.USD","LU2211815571.USD","LU1061106388.HKD","SG9999001176.USD","LU2552382058.USD","LU0471298777.SGD","IE00BJLML261.HKD","IE0004445015.USD","LU0823434583.USD","LU0820562030.AUD","LU2462157665.USD","LU1983299246.USD","LU1720051108.HKD","LU2552382132.HKD","LU2468319806.SGD","IE00BJJMRY28.SGD","IE00BJJMRX11.SGD","GB00BDT5M118.USD","LU0133085943.USD","IE00B1XK9C88.USD","LU1917777945.USD","LU2063271972.USD","SG9999014906.USD","LU2491049909.HKD","LU0158827781.USD","LU0210536198.USD","LU0323591593.USD","BK4533","LU2089283258.USD","BK4599","LLYZ","LU0672654240.SGD","LU2087625088.SGD","LU1551013425.SGD","LU0823416689.USD","LU2111349929.HKD","SGXZ99366536.SGD","IE00B7KXQ091.USD","IE00BWXC8680.SGD","LU2324357040.USD","IE00BKDWB100.SGD","IE0009355771.USD","NVO","LU1868837136.USD","LU1093756325.SGD","SG9999015945.SGD","LU0198837287.USD","IE00BFSS7M15.SGD","LU1989771016.USD","LU1366192091.USD","LU1093756168.USD","IE00BK4W5L77.USD","LU0225283273.USD","BK4581","LU2237443895.HKD","LU0786609619.USD","LU0320765059.SGD","LU2357305700.SGD","LU0640476718.USD","LU0823434740.USD","SGXZ31699556.SGD","IE00B775H168.HKD","LU2756315664.SGD","LU1868836914.USD","LU2106854487.HKD","LU0943347566.SGD","LU2264538146.SGD","SG9999001176.SGD","LU2168564065.EUR","LU0466842654.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185465612","title":"礼来、诺和诺德涨超5%，多项并购、研发进展及产能优化利好共振","url":"https://stock-news.laohu8.com/highlight/detail?id=1185465612","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1185465612?lang=zh_cn&edition=full","pubTime":"2026-06-04 22:57","pubTimestamp":1780585052,"startTime":"0","endTime":"0","summary":"近期利好频传。","market":"us","thumbnail":"https://static.tigerbbs.com/383539e68cf14d4cde7a90d97b6a4424","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/383539e68cf14d4cde7a90d97b6a4424"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"986bfebb17fba902db75e9cba66f1f6a","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVOH","NVOX","NVO","LLY"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2640970210","title":"诺和诺德在阿联酋上市维格维口服减肥药，系美国以外首个落地市场","url":"https://stock-news.laohu8.com/highlight/detail?id=2640970210","media":"环球市场播报","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640970210?lang=zh_cn&edition=full","pubTime":"2026-06-03 17:28","pubTimestamp":1780478880,"startTime":"0","endTime":"0","summary":"诺和诺德于阿联酋推出减肥口服药维格维。这是该款药片在美国本土之外的首个上市市场。　　这家丹麦药企周三宣布，减肥口服药维格维正式登陆阿联酋，这也是该药品首次在美国以外地区上市。　　诺和诺德在 5 月初发布一季报时曾透露，在取得各国药监审批后，将于 2026 年下半年在部分海外国家上市这款口服减肥药，当时未披露具体落地国家。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-06-03/doc-iniacnuq4163888.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4532","BK4599","LU1093756325.SGD","IE00BKVL7J92.USD","LU0154236417.USD","NVOH","BK4007","NVOX","BK4588","LU1093756168.USD","NVO","BK4585","IE00BZ1G4Q59.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640339909","title":"Gate 股票衍生品专区将首发上线 NVO（诺和诺德）、NOK（诺基亚）等 6 个永续合约交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2640339909","media":"链捕手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640339909?lang=zh_cn&edition=full","pubTime":"2026-06-01 13:39","pubTimestamp":1780292398,"startTime":"0","endTime":"0","summary":" ChainCatcher 消息，据官方消息，Gate 股票衍生品专区将于 6 月 1 日 14:00（UTC+8）首发上线 NVO（诺和诺德）、NOK（诺基亚）、ASTS（AST 太空移动）、AAOI（应用光电）、INFQ (Infleqtion)、CRWD（众击）永续合约交易（USDT 结算），支持 1-20 倍杠杆。\n ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.chaincatcher.com/article/2268446","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4599","NOK","BK4532","BK4547","LU1093756168.USD","IE00BMPRXR70.SGD","LU1093756325.SGD","NVOH","BK4020","IE00BKVL7J92.USD","IE00BMPRXN33.USD","LNOK","NVOX","LU0154236417.USD","BK4585","IE00BZ1G4Q59.USD","GATE","BK4588","NVO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639626600","title":"诺和诺德：印度批准维格维用于青少年群体","url":"https://stock-news.laohu8.com/highlight/detail?id=2639626600","media":"环球市场播报","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2639626600?lang=zh_cn&edition=full","pubTime":"2026-05-29 17:56","pubTimestamp":1780048560,"startTime":"0","endTime":"0","summary":"诺和诺德印度公司向彭博社书面回应称，印度中央药品标准管控局已批准爆款减肥药Wegovy 上市，适用人群为12周岁及以上、体重超60公斤（132磅） 的青少年。\n　　该企业表示，儿童肥胖问题日益严峻，已成为一大公共健康难题，且会带来长期健康隐患；该药物的使用须由医护人员评估判定。\n　　药企同时指出，这款药物针对青少年的用药剂量与售价将和成人版本保持一致。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：刘明亮","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-05-29/doc-inhzqimp7582428.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4588","LU0154236417.USD","BK4599","IE00BZ1G4Q59.USD","BK4532","NVOX","NVOH","NVO","LU1093756168.USD","LU1093756325.SGD","BK4585","IE00BKVL7J92.USD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637434972","title":"诺和诺德高剂量Wegovy单剂量注射笔获欧盟CHMP积极意见","url":"https://stock-news.laohu8.com/highlight/detail?id=2637434972","media":"环球市场播报","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637434972?lang=zh_cn&edition=full","pubTime":"2026-05-23 03:00","pubTimestamp":1779476452,"startTime":"0","endTime":"0","summary":"诺和诺德于5月22日宣布，欧洲药品管理局人用药品委员会已采纳积极意见，推荐批准Wegovy 7.2 mg单剂量注射笔在欧盟上市，用于成人肥胖症患者的体重管理。此次获批的单剂量注射笔将三针合为一体，大幅提升了用药便利性。　　诺和诺德预计将于2026年第三季度在欧盟正式推出Wegovy 7.2 mg单剂量注射笔。该产品已在美国以Wegovy HD品牌名上市销售。受此消息提振，诺和诺德股价当日上涨约2.4%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-05-23/doc-inhyvhtw8043890.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"sina_us","symbols":["IE00BKVL7J92.USD","BK4532","NVOX","LU0154236417.USD","BK4007","NVO","BK4588","LU1093756168.USD","LU1093756325.SGD","NVOH","BK4599","BK4585","IE00BZ1G4Q59.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637334393","title":"诺和诺德(NVO)Wegovy获欧洲背书 GLP1赛道竞争持续升温","url":"https://stock-news.laohu8.com/highlight/detail?id=2637334393","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637334393?lang=zh_cn&edition=full","pubTime":"2026-05-22 22:58","pubTimestamp":1779461893,"startTime":"0","endTime":"0","summary":"在此之前，Wegovy的每周皮下注射剂型已在欧洲获批上市，用于体重管理。早在去年12月，该药物已获美国FDA批准，诺和诺德也于今年正式将其推向美国口服减肥药市场。除诺和诺德外，药企礼来的每日口服减重疗法Foundayo也已登陆美国市场，两大药企形成正面竞争格局。","market":"sg","thumbnail":"https://static.szfiu.com/news/20210810/NTA4OTM0NjA2MTc=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/NTA4OTM0NjA2MTc=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"300754","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1093756325.SGD","NVOX","IE00BZ1G4Q59.USD","BK4588","BK4585","NVO","BK4532","IE00BKVL7J92.USD","LU0154236417.USD","NVOH","BK4599","LU1093756168.USD","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637336886","title":"减重神药或能抑制癌症发展，诺和诺德、礼来迎重磅利好","url":"https://stock-news.laohu8.com/highlight/detail?id=2637336886","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637336886?lang=zh_cn&edition=full","pubTime":"2026-05-22 06:52","pubTimestamp":1779403947,"startTime":"0","endTime":"0","summary":"四项覆盖数十万患者的研究显示，Ozempic（司美格鲁肽）、Mounjaro（替尔泊肽）等明星减肥药或能抑制癌症发展——肺癌进展率近乎减半，乳腺癌五年生存率从89.5%跃升至95%以上。研究人员指出，现有证据仅显示关联性，而非因果关系。若抗癌效益最终获证，将再度重塑诺和诺德与礼来的医学与商业版图。","market":"other","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"6e7a4338b1034ad785d5025385d8625c","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3772873","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1551013425.SGD","LU0203201768.USD","IE00BN29S564.USD","LU2324357040.USD","LU2168564495.EUR","IE0001KFT4U8.USD","LU1917777945.USD","LU1868836757.USD","IE00BKDWB100.SGD","LU1035775433.USD","LU2111349929.HKD","SG9999014906.USD","LU0316494557.USD","SG9999015978.USD","LU1551013342.USD","LU0353189763.USD","IE00BJT1NW94.SGD","LU1280957306.USD","SG9999001176.USD","LU2237443465.HKD","LU2491050071.SGD","ELIS","LU0320765992.SGD","LU1868836591.USD","LU1868836914.USD","LU1057294990.SGD","LU2108987350.USD","BK4585","IE00B1BXHZ80.USD","LU0820562030.AUD","LU1712237335.SGD","LU2471134879.HKD","LU2756315318.SGD","LU1291159041.SGD","LU0289739699.SGD","LU1366192091.USD","NVOX","LU1232071149.USD","LU2168564065.EUR","LU1093756325.SGD","LU2360106947.USD","LU0256863902.USD","LU0097036916.USD","IE00B2B36J28.USD","LU0353189680.USD","IE00BJJMRX11.SGD","LU0323591593.USD","LU2552382058.USD","SGXZ51526630.SGD","LU0096364046.USD","LU1023059063.AUD","IE00BJJMRY28.SGD","LU0266013472.USD","LU0456855351.SGD","LU1629891620.HKD","LU0708995401.HKD","LU2237438978.USD","LU0061475181.USD","LU0198837287.USD","LU0882574139.USD","LU0889565916.HKD","LU1720051017.SGD","LU2265009873.SGD","LU0109391861.USD","SG9999015945.SGD","LU2023251221.USD","IE0002141913.USD","LU1061106388.HKD","LU2087625088.SGD","LU2750360997.AUD","LU2471134523.USD","IE0009355771.USD","LU1093756168.USD","LU2361045086.USD","LU1720051108.HKD","LU2168563687.JPY","IE00B1XK9C88.USD","LU1623119135.USD","LU0683600562.USD","LU0094547139.USD","BK4534","LU0133085943.USD","LU2023250504.SGD","LU2750360641.GBP","LU2756315664.SGD","LU0943347566.SGD","LU2896262040.SGD","LLYX","LU2213496289.HKD","SGXZ81514606.USD","IE00BFTCPJ56.SGD","LU0109394709.USD","LU1974910355.USD","SG9999014880.SGD","LU0225283273.USD","ELIL","LU0786609619.USD","LU0417517546.SGD","IE00BJLML261.HKD","LU1145028129.USD","LU0787776722.HKD","LU1267930730.SGD","LU2237443622.USD","IE00BKVL7J92.USD","LU0238689110.USD","LU2089284900.SGD","LU0106261372.USD","LU2237443978.SGD","LU2746668461.USD","LU2552382215.SGD","LU2461242641.AUD","LU0354030511.USD","LU0471298694.HKD","SG9999018865.SGD","LU0672654240.SGD","LU0823434583.USD","LU0689472784.USD","LU0006306889.USD","LU0210536198.USD","LU2237443895.HKD","LU2361044865.SGD","LU2168564222.USD","LU2089283258.USD","SG9999014898.SGD","LU0158827781.USD","LU1814569148.SGD","LU2106854487.HKD","SG9999015986.USD","LU0820561909.HKD","LU2491049909.HKD","SG9999013999.USD","IE00BK4W5L77.USD","LU2491050154.USD","BK4533","BK4532","IE00BJJMRZ35.SGD","LU0823416689.USD","LU2168564149.EUR","LU2417539215.USD","LU0203202063.USD","LU1127390331.HKD","IE00BFSS8Q28.SGD","LU2471134796.USD","LU0158827948.USD","LU2746668974.SGD","LU1868837300.USD","IE00BKPKM429.USD","LU2063271972.USD","LU2456880835.USD","BK4581","LU0640476718.USD","IE00B7KXQ091.USD","IE00BWXC8680.SGD","LU2237443549.SGD","LU2264538146.SGD","IE0004445239.USD","LU2471134952.CNY","LU2468319806.SGD","NVOH","LU0882574055.USD","LU0058720904.USD","SG9999017495.SGD","SGXZ57979304.SGD","LU0964807845.USD","NVO","IE00BZ1G4Q59.USD","LU1988902786.USD","LU1323610961.USD","LU1868837136.USD","LU1989771016.USD","LU2028103732.USD","LU0256863811.USD","LU2237443382.USD","IE00B4R5TH58.HKD","LU0154236417.USD","BK4588","LU0466842654.USD","LU2357305700.SGD","LU2361044949.HKD","SGXZ31699556.SGD","BK4516","LU1804176565.USD","LU0122379950.USD","LU0114720955.EUR","LU1069344957.HKD","LU2089984988.USD","SG9999014914.USD","SG9999018857.SGD","BK4007","LU0354030438.USD","GB00BDT5M118.USD","LU2462157665.USD","LLY","LU0079474960.USD","IE00BFSS7M15.SGD","LU0432979614.USD","SGXZ99366536.SGD","IE0004445015.USD","IE00B775H168.HKD","LU2112291526.USD","LU2211815571.USD","LLYZ","LLII","LU2602419157.SGD","IE00B4JS1V06.HKD","SG9999015952.SGD","LU1064131342.USD","LU1548497426.USD","LU0823434740.USD","LU1983299246.USD","LU2023250330.USD","SG9999001176.SGD","IE0005OL40V9.USD","IE00BK4W5M84.HKD","LU0234572021.USD","LU2552382132.HKD","LU0820561818.USD","BK4599","LU0471298777.SGD","LU2271345857.HKD","LU2236285917.USD","LU0320765059.SGD","LU0385154629.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636028536","title":"诺和诺德计划推动Wegovy口服减肥药登陆美国以外市场","url":"https://stock-news.laohu8.com/highlight/detail?id=2636028536","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636028536?lang=zh_cn&edition=full","pubTime":"2026-05-18 15:40","pubTimestamp":1779090023,"startTime":"0","endTime":"0","summary":"诺和诺德透露，随着减肥药市场的全球争夺战愈演愈烈，公司正准备全力推动旗下Wegovy口服减肥药登陆美国以外市场。　　目前诺和诺德及其主要竞争对手礼来制药，过半以上销售额都来自美国市场。　　拉森并未透露Wegovy口服药首批出海上市的具体国家，只表示药企会依照市场潜力进行布局，同时会考量当地肥胖症患者需求、医生专业素养以及远程医疗合作资源等条件。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-05-18/doc-inhyiewm2822146.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina_us","symbols":["BK4599","NVO","NVOH","LU1093756168.USD","LU1093756325.SGD","BK4007","IE00BKVL7J92.USD","BK4588","BK4585","LU0154236417.USD","BK4532","NVOX","IE00BZ1G4Q59.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635842857","title":"减重赛道激战正酣：跨国巨头齐亮剑，竞争升维至全病程管理","url":"https://stock-news.laohu8.com/highlight/detail?id=2635842857","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635842857?lang=zh_cn&edition=full","pubTime":"2026-05-13 19:54","pubTimestamp":1778673240,"startTime":"0","endTime":"0","summary":"在2026年世界防治肥胖日到来、“体重管理年”行动收官的关键节点，全球减重药物市场的火药味达到了新的浓度。从伊斯坦布尔第33届欧洲肥胖大会（ECO），到国内学术峰会，诺和诺德、礼来以及辉瑞/先为达等跨国药企与本土创新力量，不约而同地选择在这一时间窗口密集“亮剑”，发布了各自在减重领域的最新重磅数据。这并非巧合。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202605133736129640.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605133736129640.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1057294990.SGD","LU0058720904.USD","BK4144","LU0225771236.USD","LU0306807586.USD","LU1894683348.USD","IE000M9KFDE8.USD","NVOH","SG9999001176.SGD","SG9999002232.USD","IE00B19Z3B42.SGD","BK4550","BK4588","LU0234572021.USD","SG9999011175.SGD","IE00BBT3K403.USD","LU0225284248.USD","SGXZ57979304.SGD","BK4534","BK4533","IE00BLSP4452.SGD","LU0321505439.SGD","LU1883839398.USD","NVOX","IE00B19Z3581.USD","LU1894683264.USD","IE00BZ1G4Q59.USD","LU1023059063.AUD","LU1066053197.SGD","ECO","SG9999001176.USD","BK4568","LU1093756325.SGD","LU0289739699.SGD","BK4592","LU0868494617.USD","PFE","NVO","LU0985481810.HKD","IE0002270589.USD","SG9999003800.SGD","BK4532","IE00BLSP4239.USD","IE00BKVL7J92.USD","LU0154236417.USD","BK4007","LU0456855351.SGD","LU0997586861.USD","BK4585","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635246753","title":"Hims & Hers公布一季度亏损、业绩指引疲软，股价暴跌15.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2635246753","media":"环球市场播报","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635246753?lang=zh_cn&edition=full","pubTime":"2026-05-13 00:46","pubTimestamp":1778604360,"startTime":"0","endTime":"0","summary":"　　数字医疗公司 Hims & Hers 周二受一季度财报疲软拖累，股价大幅下挫。　　公司一季度净亏损达 9200 万美元，高于去年同期的 5000 万美元。该公司近期与诺和诺德达成合作，将在平台销售其品牌减肥药。　　远程医疗企业 Hims & Hers 发布一季度亏损业绩，且全年业绩指引偏弱，周二股价应声大跌。　　该股最新跌幅15.2%。　　“这次合作和上次完全不同。Hims & Hers 已承诺，在上架我方正品后，不再向大众宣传、推广复方仿制类减肥药。”","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-05-13/doc-inhxsiea9781441.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["HIMS","BK4007","LU1093756325.SGD","BK4585","LU0154236417.USD","LU1093756168.USD","BK4599","NVOH","BK4532","NVOX","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137321098","title":"市场聚焦：游戏驿站、Venture Global、温蒂汉堡、Hims & Hers等个股动态","url":"https://stock-news.laohu8.com/highlight/detail?id=1137321098","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1137321098?lang=zh_cn&edition=full","pubTime":"2026-05-12 20:09","pubTimestamp":1778587787,"startTime":"0","endTime":"0","summary":"游戏驿站 ：这家视频游戏零售商的董事会拒绝了eBay主动提出的560亿美元收购要约，其股价在盘前交易中应声下跌。Venture Global ：这家液化天然气出口商报告第一季度营收和利润大幅增长后，其股价在盘前交易中上涨了9%。Hims & Hers ：这家远程医疗平台的股价在盘前下跌了15%，原因是该公司表示，其调整减肥产品线的举措推高了成本。ZoomInfo Technologies Inc. ：这家市场情报公司的股价在周一晚些时候下调全年业绩指引后大幅下挫。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"c1ee3020066801ecc9807d71c3848eaf","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4077","BK4023","BK4213","BK4202","NVOH","BK4532","HIMS","IE00BKVL7J92.USD","IGME","BK4196","BK4588","GMEU","BK4078","HIMZ","LU1093756325.SGD","HIYY","GPRO","UA","GTM","BK4076","HIMY","GME","BK4599","WEN","BK4577","HMYY","NVOX","BK4585","GMEY","NVO","BK4209","BAYRY","BK4007","BK4547","LU0154236417.USD","VG","LU1093756168.USD","IE00BZ1G4Q59.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.0044},{"period":"1month","weight":-0.1462},{"period":"3month","weight":0.318},{"period":"6month","weight":-0.3639},{"period":"1year","weight":-0.7973},{"period":"ytd","weight":-0.3732}],"compareEarnings":[{"period":"1week","weight":-0.0255},{"period":"1month","weight":-0.0006},{"period":"3month","weight":0.114},{"period":"6month","weight":0.0821},{"period":"1year","weight":0.2268},{"period":"ytd","weight":0.0819}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"exchange":"ARCA","name":"2倍做多NVO ETF-Defiance","nameEN":"Defiance Daily Target 2X Long NVO ETF"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"2倍做多NVO ETF-Defiance(NVOX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供2倍做多NVO ETF-Defiance(NVOX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"2倍做多NVO ETF-Defiance,NVOX,2倍做多NVO ETF-Defiance股票,2倍做多NVO ETF-Defiance股票老虎,2倍做多NVO ETF-Defiance股票老虎国际,2倍做多NVO ETF-Defiance行情,2倍做多NVO ETF-Defiance股票行情,2倍做多NVO ETF-Defiance股价,2倍做多NVO ETF-Defiance股市,2倍做多NVO ETF-Defiance股票价格,2倍做多NVO ETF-Defiance股票交易,2倍做多NVO ETF-Defiance股票购买,2倍做多NVO ETF-Defiance股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"2倍做多NVO ETF-Defiance(NVOX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供2倍做多NVO ETF-Defiance(NVOX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}